For example, CR cells were established from PDX models with pancreatic ductal adenocarcinoma cells [60], a novel potential therapeutic target, ERCC3-Myc interaction, and a covalent inhibitor of ERCC3, triptolide, have been identified from CR cells [60]. The gene discussed is ERCC3; the disease is pancreatic ductal adenocarcinoma.